Companies / Switzerland
Merck KGaA Bids For Serono
September 2006 | Company News AlertIn a shock move, German firm Merck KGaA has unveiled a US$13.3bn bid for Swiss biotechnology company Serono, to create a new heavyweight player in the European pharmaceuticals sector.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
